세계의 단백질체학 시장 보고서(2025년)
Proteomics Global Market Report 2025
상품코드 : 1824506
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

단백질체학 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 연평균 성장률(CAGR) 13.3%로 648억 9,000만 달러로 성장할 것입니다. 예측 기간의 성장은 벤처기업에 대한 자금 조달 증가, 맞춤형 의료에 대한 요구 증가, 연구개발 활동 증가, COVID-19 사태로 인한 바이오테크 기업에 대한 투자 증가에 기인합니다. 예측 기간의 주요 동향으로는 저농도 시료 식별을 위한 나노기술에 대한 관심, 신기술 개발 및 발전, 신제품 출시, 인공지능(AI) 및 실시간 개선된 이미징과 같은 기술에 대한 투자 등이 있습니다.

향후 5년간 13.3%의 성장률 전망은 지난번 예측보다 0.3% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 일본에서 조달하는 액체 크로마토그래피 컬럼과 고해상도 질량분석기 비용을 상승시켜 대규모 단백질체학 연구를 지연시키고, 학술 기관과 임상 연구소의 비용을 상승시킴으로써 미국을 저해할 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

단백질체학 시장의 발전은 단백질체학 연구에 대한 정부 자금 배분 증가에 의해 촉진될 것입니다. 정부 지원금은 신약개발, 질병 진단, 치료에 종사하는 연구자들에게 중요한 지원이 될 수 있습니다. 호주에 본사를 둔 의료 기술 기업 Proteomics International Laboratories Limited는 2022년 5월 호주에서 제조 능력을 강화하기 위해 40만 달러의 자금을 확보했습니다. 이번 자금 지원은 단백질체학 인터내셔널의 전문적인 ISO 13485 인증 확대와 함께 호주와 동남아시아에서 PromarkerD 검사의 생산 촉진을 목표로 하고 있습니다. 결과적으로 정부 자금의 증가는 단백질체학 시장에 긍정적인 영향을 미칠 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Proteomics involves the examination of the structure and functions of proteins, playing a crucial role in drug discovery, disease diagnosis, and treatment. It is employed to assess the production rate of proteins, the participation of proteins in metabolic pathways, and the modifications undergone by proteins.

The primary categories of proteomics include protein microarrays, spectroscopy, X-ray crystallography, chromatography, electrophoresis, surface plasmon resonance, and protein fractionation. The essential elements utilized in proteomics encompass reagents, instruments, and software, all contributing to proteomic analytical services and instrument services.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The proteomics market research report is one of a series of new reports from The Business Research Company that provides proteomics market statistics, including proteomics industry global market size, regional shares, competitors with a proteomics market share, detailed proteomics market segments, market trends, and opportunities, and any further data you may need to thrive in the proteomics industry. This proteomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The proteomics market size has grown rapidly in recent years. It will grow from $34.83 billion in 2024 to $39.37 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increase in government funds for research on proteomics, advancement in technologies, rise in healthcare expenditure, growth in the number of healthcare facilities and economic growth in emerging markets.

The proteomics market size is expected to see rapid growth in the next few years. It will grow to $64.89 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing financing for proteomics ventures, rising requirement for customized medicine, increasing research and development activities and growth in investments in biotech companies attributing to COVID-19 outbreak. Major trends in the forecast period include focus on considering nanotechnology for identifying low-abundant samples, developing and advancing new technologies, launching new products, invest in technology such as artificial intelligence (AI) and real time improved imaging.

The forecast of 13.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of liquid chromatography columns and high-resolution mass spectrometers sourced from Germany and Japan, thereby delaying large-scale proteomic studies and elevating academic and clinical lab expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The advancement of the proteomics market is propelled by the increasing allocation of government funds towards proteomics research. Government funding serves as a crucial support for researchers engaged in drug discovery, disease diagnosis, and treatment. A case in point is Proteomics International Laboratories Limited, an Australia-based medical technology company, which, in May 2022, secured $400,000 in funding to enhance its manufacturing capabilities in Australia. This financial support aims to facilitate the production advancement of the PromarkerD test in Australia and South-East Asia, involving the expansion of Proteomics International's specialized ISO 13485 certification. Consequently, the rise in government funds has a positive impact on the proteomics market.

The expanding pharmaceutical industry is anticipated to drive the future growth of the proteomics market. The pharmaceutical sector, dedicated to the research, development, manufacturing, and distribution of drugs and medications, heavily relies on proteomics for drug development. Proteomics plays a vital role in identifying, characterizing, and monitoring proteins for drug targets and biomarker discovery. For example, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, in June 2023, the total pharmaceutical production in Europe reached $400,200 million (€340,000 million) in 2022, indicating an increase from $381,641 million (€323,950 million) in 2021. Hence, the burgeoning pharmaceutical industry acts as a driving force for the growth of the proteomics market.

Companies are launching new products to boost their revenue and gain a competitive edge over their rivals. For example, in June 2022, Bruker Corporation, a US-based manufacturer of scientific instruments, introduced the latest advancement in its 4D Multiomics timsTOF platform with the new timsTOF HT system. This system features an innovative 4th-generation TIMS (trapped ion mobility separation) XR cell and a 14-bit digitizer, providing an expanded dynamic range, improved peptide coverage, and enhanced quantitation accuracy, particularly in unbiased 4D plasma and tissue proteomics, as well as epiproteomics.

Key players in the proteomics market are strategically focusing on the development of precise quantitative analysis kits to enhance their competitive position. These kits are instrumental in accurately measuring protein expression levels and identifying biomarkers across various biological samples. For instance, in January 2023, SCIEX, a US-based manufacturer of mass spectrometry instrumentation, launched the Fast Glycan Labeling and Analysis kit and an update for the Biologics Explorer software. This kit is specifically designed for precise quantitative glycan analysis, while the software update aims to enhance key workflows for the analysis of protein therapeutics. These solutions accelerate the examination and identification of glycans associated with proteins, providing researchers with advanced resources for comprehensive biopharmaceutical analysis. The software empowers researchers to make informed decisions regarding the most suitable analytical methods and tools for their specific applications, ultimately improving the efficiency and effectiveness of protein characterization studies.

In July 2024, Thermo Fisher Scientific, a US-based life science and clinical research company, acquired Olink Holding for approximately $3.1 billion. This acquisition aligns with Thermo Fisher's strategy to enhance its portfolio of innovative technologies. The company intends to leverage Olink's proprietary Proximity Extension Assay (PEA) technology, which facilitates high-throughput protein analysis for quantitative polymerase chain reaction and next-generation sequencing readout systems. PEA features a library of over 5,300 validated protein biomarker targets, significantly enhancing Thermo Fisher's capabilities in proteomics research. Olink Holding is a Sweden-based provider of next-generation proteomics solutions.

Major companies operating in the proteomics market include Danaher Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, Bio-Rad Laboratories Inc., Promega Corporation, Waters Corporation, Creative Proteomics, Sino Biological, EIAab, DIMA Biotechnology, TechnoConcept India Pvt. Ltd., Cellular & Molecular Biology, GE Healthcare, Perseus Proteomics Inc., JEOL, APTBIO, Leisure Science (Suzhou) Co. Ltd., Centre for Cellular & Molecular Biology, Vproteomics, Shimadzu Corporation, Abcam plc, IRB Barcelona, SGS UK, MRM Proteomics Inc., FingerPrints, Biognosys AG, Olink Proteomics, Horiba, MS Bioworks, LC Sciences, MtoZ Biolabs, Integrated Proteomics Applications, Quantumbio Inc., Luminex Corporation, Applied Biomics Inc., Isoplexis Corporation, Caprion Proteomics Inc.

North America was the largest region in the proteomics market in 2024. Western Europe was the second largest region in the global proteomics market share. The regions covered in the proteomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the proteomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The proteomics market consists of sales of proteins that are used for drug discovery, clinical diagnosis, molecular medicine and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Proteomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on proteomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for proteomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The proteomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Proteomics Market Characteristics

3. Proteomics Market Trends And Strategies

4. Proteomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Proteomics Growth Analysis And Strategic Analysis Framework

6. Proteomics Market Segmentation

7. Proteomics Market Regional And Country Analysis

8. Asia-Pacific Proteomics Market

9. China Proteomics Market

10. India Proteomics Market

11. Japan Proteomics Market

12. Australia Proteomics Market

13. Indonesia Proteomics Market

14. South Korea Proteomics Market

15. Western Europe Proteomics Market

16. UK Proteomics Market

17. Germany Proteomics Market

18. France Proteomics Market

19. Italy Proteomics Market

20. Spain Proteomics Market

21. Eastern Europe Proteomics Market

22. Russia Proteomics Market

23. North America Proteomics Market

24. USA Proteomics Market

25. Canada Proteomics Market

26. South America Proteomics Market

27. Brazil Proteomics Market

28. Middle East Proteomics Market

29. Africa Proteomics Market

30. Proteomics Market Competitive Landscape And Company Profiles

31. Proteomics Market Other Major And Innovative Companies

32. Global Proteomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Proteomics Market

34. Recent Developments In The Proteomics Market

35. Proteomics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기